Shorter vs standard breast radiation after lumpectomy
Part of Cancer, Skin clinical trials.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and age 18–70
- Your breast cancer was removed with lumpectomy, with clear (negative) margins
- Your cancer is invasive breast cancer (not only DCIS), and has no distant spread
- You have either sentinel node biopsy only or a specific axillary node surgery plan, based on results
- You can safely receive radiation after surgery (no major radiation contraindications) and can complete follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests whether a shorter course of radiation therapy (called hypofractionated) after lumpectomy is safe and works well for early breast cancer. It aims to make treatment more convenient while keeping the same benefits.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial compares two different schedules of radiation therapy after mastectomy and breast reconstruction. One uses standard daily doses over a longer period, and the other uses higher doses over a shorter period. The goal is to see if the shorter schedule works just as well while possibly saving time and reducing side effects.
This trial compares two different schedules of radiation therapy after breast cancer surgery to see if a shorter course is as effective. It may help reduce the number of hospital visits for patients who have had breast-conserving surgery or a mastectomy.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.